Curatis Holding AG | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
Curatis Holding AG

BRIEF

published on 09/05/2025 at 07:05, 3 months ago

Curatis va augmenter ses revenus grâce à un partenariat avec Phoenix Labs

Suisse Accord De Distribution Croissance Des Revenus Curatis Laboratoires Phoenix
PRESS RELEASE

published on 09/05/2025 at 07:00, 3 months ago

Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG announces new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland, expecting up to CHF 5 million additional annual revenues from October 2025

Revenue Growth Switzerland Curatis Holding AG Phoenix Labs Distribution Contract
BRIEF

published on 07/31/2025 at 06:05, 4 months 5 days ago

La FDA organise une réunion de type B pour l'essai de phase 3 de Curatis sur la corticoréline

Essai De Phase 3 Curatis Holding AG Réunion De La FDA Corticoréline Traitement PTBE
BRIEF

published on 07/31/2025 at 06:05, 4 months 5 days ago

FDA Schedules Type B Meeting for Curatis' Phase 3 Corticorelin Trial

Phase 3 Trial Curatis Holding AG FDA Meeting Corticorelin PTBE Treatment
PRESS RELEASE

published on 07/31/2025 at 06:00, 4 months 5 days ago

FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
FDA confirms Type B meeting with Curatis Holding AG to review Phase 3 plan for investigational biologic corticorelin, targeting Peritumoral Brain Edema. Development aims to reduce steroid use in patients

FDA Phase 3 Study Curatis Holding AG Corticorelin Type B Meeting
BRIEF

published on 05/24/2025 at 11:36, 6 months 11 days ago

L'assemblée générale annuelle de Curatis Holding AG approuve les propositions du conseil d'administration

Conseil D'administration SIX Swiss Exchange Curatis Holding AG Approbation De L'AGA Société Pharmaceutique
BRIEF

published on 05/24/2025 at 11:36, 6 months 11 days ago

Curatis Holding AG's AGM Approves Board's Proposals

Board Of Directors Pharmaceutical Company SIX Swiss Exchange Curatis Holding AG AGM Approval
PRESS RELEASE

published on 05/24/2025 at 11:31, 6 months 11 days ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Curatis Holding AG shareholders approve all proposals at Annual General Meeting including annual report and 2024 financial year. Details of re-elected board members and company focus on rare diseases

Annual General Meeting Shareholders Financial Year 2024 Rare Diseases Curatis Holding AG
BRIEF

published on 05/23/2025 at 07:05, 6 months 13 days ago

Curatis dévoile la corticoréline et vise un marché du PTBE d'un milliard de dollars

Essais Cliniques Opportunité De Marché Corticoréline Traitement PTBE Agrandissement De L'équipe
BRIEF

published on 05/23/2025 at 07:05, 6 months 13 days ago

Curatis Unveils Corticorelin and Eyes $1 Billion PTBE Market

Clinical Trials Team Expansion Market Opportunity Corticorelin PTBE Treatment

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 34 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 4 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 43 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 9 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 19 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 20 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE